APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma Excipients

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharma Excipients Industry Growth and Trends Forecast to 2032

19 December 202594 pages

Choose your research edition.

Industry ResearchPharma Excipients Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Excipients Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Pharma Excipients Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Excipients Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Excipients Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pharma Excipients market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharma Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharma Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharma Excipients is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharma Excipients include J.M. Huber Corporation, Evonik, Eastman Chemical Company, DOW Chemical Company, Cargill, BASF, Archer Daniels Midland (ADM), AkzoNobel and ABITEC Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharma Excipients market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharma Excipients market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharma Excipients market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharma Excipients.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pharma Excipients market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharma Excipients Market by Company

J.M. Huber Corporation

Evonik

Eastman Chemical Company

DOW Chemical Company

Cargill

BASF

Archer Daniels Midland (ADM)

AkzoNobel

ABITEC Corporation

Pharma Excipients Segment by Type

Alcohols

Polymers

Minerals

Sugar

Others

Pharma Excipients Segment by Application

Oral Solid Dosage Forms (OSDF)

Others

Pharma Excipients Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Excipients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Excipients and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Excipients.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharma Excipients manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pharma Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Alcohols Table 2. Major Company of Polymers Table 3. Major Company of Minerals Table 4. Major Company of Sugar Table 5. Major Company of Others Table 6. Global Pharma Excipients Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 8. Global Pharma Excipients Sales Market Share in Volume by Type (2021-2026) Table 9. Global Pharma Excipients Sales by Type (2021-2026) & (US$ Million) Table 10. Global Pharma Excipients Sales Market Share in Value by Type (2021-2026) Table 11. Global Pharma Excipients Price by Type (2021-2026) & (US$/Ton) Table 12. Global Pharma Excipients Sales by Type (2027-2032) & (W Tons) Table 13. Global Pharma Excipients Sales Market Share in Volume by Type (2027-2032) Table 14. Global Pharma Excipients Sales by Type (2027-2032) & (US$ Million) Table 15. Global Pharma Excipients Sales Market Share in Value by Type (2027-2032) Table 16. Global Pharma Excipients Price by Type (2027-2032) & (US$/Ton) Table 17. North America Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 18. North America Pharma Excipients Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 20. Europe Pharma Excipients Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 22. Asia-Pacific Pharma Excipients Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 24. Latin America Pharma Excipients Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Pharma Excipients Sales by Type (2021-2026) & (W Tons) Table 26. Middle East and Africa Pharma Excipients Sales by Type (2021-2026) & (US$ Million) Table 27. Pharma Excipients Industry Trends Table 28. Pharma Excipients Industry Drivers Table 29. Pharma Excipients Industry Opportunities and Challenges Table 30. Pharma Excipients Industry Restraints Table 31. Global Pharma Excipients Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Pharma Excipients Revenue Market Share by Company (2021-2026) Table 33. Global Pharma Excipients Sales by Company (2021-2026) & (W Tons) Table 34. Global Pharma Excipients Sales Share by Company (2021-2026) Table 35. Global Pharma Excipients Market Price by Company (2021-2026) & (US$/Ton) Table 36. Global Pharma Excipients Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Pharma Excipients Major Company Production Sites and Headquarters Table 38. Global Pharma Excipients Company, Product Type & Application Table 39. Global Pharma Excipients Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Pharma Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Pharma Excipients Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Pharma Excipients Sales by Region (2021-2026) & (W Tons) Table 44. Global Pharma Excipients Sales Market Share in Volume by Region (2021-2026) Table 45. Global Pharma Excipients Sales by Region (2021-2026) & (US$ Million) Table 46. Global Pharma Excipients Sales Market Share in Value by Region (2021-2026) Table 47. Global Pharma Excipients Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 48. Global Pharma Excipients Sales by Region (2027-2032) & (W Tons) Table 49. Global Pharma Excipients Sales Market Share in Volume by Region (2027-2032) Table 50. Global Pharma Excipients Sales by Region (2027-2032) & (US$ Million) Table 51. Global Pharma Excipients Sales Market Share in Value by Region (2027-2032) Table 52. Global Pharma Excipients Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 53. Global Pharma Excipients Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 55. Global Pharma Excipients Sales Market Share in Volume by Application (2021-2026) Table 56. Global Pharma Excipients Sales by Application (2021-2026) & (US$ Million) Table 57. Global Pharma Excipients Sales Market Share in Value by Application (2021-2026) Table 58. Global Pharma Excipients Price by Application (2021-2026) & (US$/Ton) Table 59. Global Pharma Excipients Sales by Application (2027-2032) & (W Tons) Table 60. Global Pharma Excipients Sales Market Share in Volume by Application (2027-2032) Table 61. Global Pharma Excipients Sales by Application (2027-2032) & (US$ Million) Table 62. Global Pharma Excipients Sales Market Share in Value by Application (2027-2032) Table 63. Global Pharma Excipients Price by Application (2027-2032) & (US$/Ton) Table 64. North America Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 65. North America Pharma Excipients Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 67. Europe Pharma Excipients Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 69. Asia-Pacific Pharma Excipients Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 71. Latin America Pharma Excipients Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Pharma Excipients Sales by Application (2021-2026) & (W Tons) Table 73. Middle East and Africa Pharma Excipients Sales by Application (2021-2026) & (US$ Million) Table 74. J.M. Huber Corporation Company Information Table 75. J.M. Huber Corporation Business Overview Table 76. J.M. Huber Corporation Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. J.M. Huber Corporation Pharma Excipients Product Portfolio Table 78. J.M. Huber Corporation Recent Development Table 79. Evonik Company Information Table 80. Evonik Business Overview Table 81. Evonik Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Evonik Pharma Excipients Product Portfolio Table 83. Evonik Recent Development Table 84. Eastman Chemical Company Company Information Table 85. Eastman Chemical Company Business Overview Table 86. Eastman Chemical Company Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Eastman Chemical Company Pharma Excipients Product Portfolio Table 88. Eastman Chemical Company Recent Development Table 89. DOW Chemical Company Company Information Table 90. DOW Chemical Company Business Overview Table 91. DOW Chemical Company Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. DOW Chemical Company Pharma Excipients Product Portfolio Table 93. DOW Chemical Company Recent Development Table 94. Cargill Company Information Table 95. Cargill Business Overview Table 96. Cargill Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 97. Cargill Pharma Excipients Product Portfolio Table 98. Cargill Recent Development Table 99. BASF Company Information Table 100. BASF Business Overview Table 101. BASF Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 102. BASF Pharma Excipients Product Portfolio Table 103. BASF Recent Development Table 104. Archer Daniels Midland (ADM) Company Information Table 105. Archer Daniels Midland (ADM) Business Overview Table 106. Archer Daniels Midland (ADM) Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 107. Archer Daniels Midland (ADM) Pharma Excipients Product Portfolio Table 108. Archer Daniels Midland (ADM) Recent Development Table 109. AkzoNobel Company Information Table 110. AkzoNobel Business Overview Table 111. AkzoNobel Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 112. AkzoNobel Pharma Excipients Product Portfolio Table 113. AkzoNobel Recent Development Table 114. ABITEC Corporation Company Information Table 115. ABITEC Corporation Business Overview Table 116. ABITEC Corporation Pharma Excipients Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 117. ABITEC Corporation Pharma Excipients Product Portfolio Table 118. ABITEC Corporation Recent Development Table 119. North America Pharma Excipients Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 120. North America Pharma Excipients Sales by Country (2021-2026) & (W Tons) Table 121. North America Pharma Excipients Sales Market Share by Country (2021-2026) Table 122. North America Pharma Excipients Sales Forecast by Country (2027-2032) & (W Tons) Table 123. North America Pharma Excipients Sales Market Share Forecast by Country (2027-2032) Table 124. North America Pharma Excipients Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Pharma Excipients Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Pharma Excipients Market Share by Country (2021-2026) Table 127. North America Pharma Excipients Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Pharma Excipients Market Share Forecast by Country (2027-2032) Table 129. Europe Pharma Excipients Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 130. Europe Pharma Excipients Sales by Country (2021-2026) & (W Tons) Table 131. Europe Pharma Excipients Sales Market Share by Country (2021-2026) Table 132. Europe Pharma Excipients Sales Forecast by Country (2027-2032) & (W Tons) Table 133. Europe Pharma Excipients Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Pharma Excipients Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Pharma Excipients Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Pharma Excipients Market Share by Country (2021-2026) Table 137. Europe Pharma Excipients Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Pharma Excipients Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Pharma Excipients Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Pharma Excipients Sales by Country (2021-2026) & (W Tons) Table 141. Asia-Pacific Pharma Excipients Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Pharma Excipients Sales Forecast by Country (2027-2032) & (W Tons) Table 143. Asia-Pacific Pharma Excipients Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Pharma Excipients Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Pharma Excipients Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Pharma Excipients Market Share by Country (2021-2026) Table 147. Asia-Pacific Pharma Excipients Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Pharma Excipients Market Share Forecast by Country (2027-2032) Table 149. Latin America Pharma Excipients Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 150. Latin America Pharma Excipients Sales by Country (2021-2026) & (W Tons) Table 151. Latin America Pharma Excipients Sales Market Share by Country (2021-2026) Table 152. Latin America Pharma Excipients Sales Forecast by Country (2027-2032) & (W Tons) Table 153. Latin America Pharma Excipients Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Pharma Excipients Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Pharma Excipients Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Pharma Excipients Market Share by Country (2021-2026) Table 157. Latin America Pharma Excipients Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Pharma Excipients Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Pharma Excipients Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Pharma Excipients Sales by Country (2021-2026) & (W Tons) Table 161. Middle East and Africa Pharma Excipients Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Pharma Excipients Sales Forecast by Country (2027-2032) & (W Tons) Table 163. Middle East and Africa Pharma Excipients Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Pharma Excipients Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Pharma Excipients Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Pharma Excipients Market Share by Country (2021-2026) Table 167. Middle East and Africa Pharma Excipients Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Pharma Excipients Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Pharma Excipients Distributors List Table 172. Pharma Excipients Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Pharma Excipients Image Figure 2. Global Pharma Excipients Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharma Excipients Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharma Excipients Sales (2021-2032) & (W Tons) Figure 5. Alcohols Image Figure 6. Global Alcohols Sales YoY Growth (2021-2032) & (W Tons) Figure 7. Polymers Image Figure 8. Global Polymers Sales YoY Growth (2021-2032) & (W Tons) Figure 9. Minerals Image Figure 10. Global Minerals Sales YoY Growth (2021-2032) & (W Tons) Figure 11. Sugar Image Figure 12. Global Sugar Sales YoY Growth (2021-2032) & (W Tons) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 15. Global Pharma Excipients Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Pharma Excipients Market Share by Type 2025 VS 2032 Figure 17. North America Pharma Excipients Sales Market Share in Volume by Type in 2025 Figure 18. North America Pharma Excipients Sales Market Share in Value by Type in 2025 Figure 19. Europe Pharma Excipients Sales Market Share in Volume by Type in 2025 Figure 20. Europe Pharma Excipients Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Pharma Excipients Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Pharma Excipients Sales Market Share in Value by Type in 2025 Figure 23. Latin America Pharma Excipients Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Pharma Excipients Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Pharma Excipients Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Pharma Excipients Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Pharma Excipients Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Oral Solid Dosage Forms (OSDF) Image Figure 30. Global Oral Solid Dosage Forms (OSDF) Sales YoY Growth (2021-2032) & (W Tons) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 33. Global Pharma Excipients Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Pharma Excipients Market Share by Application 2025 VS 2032 Figure 35. North America Pharma Excipients Sales Market Share in Volume by Application in 2025 Figure 36. North America Pharma Excipients Sales Market Share in Value by Application in 2025 Figure 37. Europe Pharma Excipients Sales Market Share in Volume by Application in 2025 Figure 38. Europe Pharma Excipients Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Pharma Excipients Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Pharma Excipients Sales Market Share in Value by Application in 2025 Figure 41. Latin America Pharma Excipients Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Pharma Excipients Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Pharma Excipients Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Pharma Excipients Sales Market Share in Value by Application in 2025 Figure 45. North America Pharma Excipients Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 46. North America Pharma Excipients Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Pharma Excipients Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Pharma Excipients Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pharma Excipients Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 50. Europe Pharma Excipients Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Pharma Excipients Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Pharma Excipients Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pharma Excipients Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 54. Asia-Pacific Pharma Excipients Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Pharma Excipients Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Pharma Excipients Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pharma Excipients Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 58. Latin America Pharma Excipients Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Pharma Excipients Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Pharma Excipients Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pharma Excipients Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 62. Middle East and Africa Pharma Excipients Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Pharma Excipients Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Pharma Excipients Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Pharma Excipients Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Pharma Excipients Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Alcohols
  • Polymers
  • Minerals
  • Sugar
  • Others
Applications
  • Oral Solid Dosage Forms (OSDF)
  • Others
Companies covered
  • J.M. Huber Corporation
  • Evonik
  • Eastman Chemical Company
  • DOW Chemical Company
  • Cargill
  • BASF
  • Archer Daniels Midland (ADM)
  • AkzoNobel
  • ABITEC Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharma Excipients Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pharma Excipients Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pharma Excipients Market by Type
  6. 1.3.1 Alcohols
  7. 1.3.2 Polymers
  8. 1.3.3 Minerals
  9. 1.3.4 Sugar
  10. 1.3.5 Others
  11. 1.4 Global Pharma Excipients Market Size by Type
  12. 1.4.1 Global Pharma Excipients Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Pharma Excipients Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Pharma Excipients Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Pharma Excipients Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Pharma Excipients Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Pharma Excipients Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Pharma Excipients Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Pharma Excipients Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pharma Excipients Industry Trends
  2. 2.2 Pharma Excipients Industry Drivers
  3. 2.3 Pharma Excipients Industry Opportunities and Challenges
  4. 2.4 Pharma Excipients Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pharma Excipients Revenue (2021-2026)
  2. 3.2 Global Top Players by Pharma Excipients Sales (2021-2026)
  3. 3.3 Global Top Players by Pharma Excipients Price (2021-2026)
  4. 3.4 Global Pharma Excipients Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharma Excipients Major Company Production Sites & Headquarters
  6. 3.6 Global Pharma Excipients Company, Product Type & Application
  7. 3.7 Global Pharma Excipients Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharma Excipients Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharma Excipients Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharma Excipients Tier 1, Tier 2, and Tier 3
4 Pharma Excipients Regional Status and Outlook
  1. 4.1 Global Pharma Excipients Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pharma Excipients Historic Market Size by Region
  3. 4.2.1 Global Pharma Excipients Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pharma Excipients Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pharma Excipients Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pharma Excipients Forecasted Market Size by Region
  7. 4.3.1 Global Pharma Excipients Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pharma Excipients Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pharma Excipients Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pharma Excipients by Application
  1. 5.1 Pharma Excipients Market by Application
  2. 5.1.1 Oral Solid Dosage Forms (OSDF)
  3. 5.1.2 Others
  4. 5.2 Global Pharma Excipients Market Size by Application
  5. 5.2.1 Global Pharma Excipients Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Pharma Excipients Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Pharma Excipients Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Pharma Excipients Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Pharma Excipients Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Pharma Excipients Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Pharma Excipients Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Pharma Excipients Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 J.M. Huber Corporation
  2. 6.1.1 J.M. Huber Corporation Company Information
  3. 6.1.2 J.M. Huber Corporation Business Overview
  4. 6.1.3 J.M. Huber Corporation Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 J.M. Huber Corporation Pharma Excipients Product Portfolio
  6. 6.1.5 J.M. Huber Corporation Recent Developments
  7. 6.2 Evonik
  8. 6.2.1 Evonik Company Information
  9. 6.2.2 Evonik Business Overview
  10. 6.2.3 Evonik Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Evonik Pharma Excipients Product Portfolio
  12. 6.2.5 Evonik Recent Developments
  13. 6.3 Eastman Chemical Company
  14. 6.3.1 Eastman Chemical Company Company Information
  15. 6.3.2 Eastman Chemical Company Business Overview
  16. 6.3.3 Eastman Chemical Company Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eastman Chemical Company Pharma Excipients Product Portfolio
  18. 6.3.5 Eastman Chemical Company Recent Developments
  19. 6.4 DOW Chemical Company
  20. 6.4.1 DOW Chemical Company Company Information
  21. 6.4.2 DOW Chemical Company Business Overview
  22. 6.4.3 DOW Chemical Company Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 DOW Chemical Company Pharma Excipients Product Portfolio
  24. 6.4.5 DOW Chemical Company Recent Developments
  25. 6.5 Cargill
  26. 6.5.1 Cargill Company Information
  27. 6.5.2 Cargill Business Overview
  28. 6.5.3 Cargill Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cargill Pharma Excipients Product Portfolio
  30. 6.5.5 Cargill Recent Developments
  31. 6.6 BASF
  32. 6.6.1 BASF Company Information
  33. 6.6.2 BASF Business Overview
  34. 6.6.3 BASF Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 BASF Pharma Excipients Product Portfolio
  36. 6.6.5 BASF Recent Developments
  37. 6.7 Archer Daniels Midland (ADM)
  38. 6.7.1 Archer Daniels Midland (ADM) Company Information
  39. 6.7.2 Archer Daniels Midland (ADM) Business Overview
  40. 6.7.3 Archer Daniels Midland (ADM) Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Archer Daniels Midland (ADM) Pharma Excipients Product Portfolio
  42. 6.7.5 Archer Daniels Midland (ADM) Recent Developments
  43. 6.8 AkzoNobel
  44. 6.8.1 AkzoNobel Company Information
  45. 6.8.2 AkzoNobel Business Overview
  46. 6.8.3 AkzoNobel Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AkzoNobel Pharma Excipients Product Portfolio
  48. 6.8.5 AkzoNobel Recent Developments
  49. 6.9 ABITEC Corporation
  50. 6.9.1 ABITEC Corporation Company Information
  51. 6.9.2 ABITEC Corporation Business Overview
  52. 6.9.3 ABITEC Corporation Pharma Excipients Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ABITEC Corporation Pharma Excipients Product Portfolio
  54. 6.9.5 ABITEC Corporation Recent Developments
7 North America by Country
  1. 7.1 North America Pharma Excipients Sales by Country
  2. 7.1.1 North America Pharma Excipients Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pharma Excipients Sales by Country (2021-2026)
  4. 7.1.3 North America Pharma Excipients Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pharma Excipients Market Size by Country
  6. 7.2.1 North America Pharma Excipients Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pharma Excipients Market Size by Country (2021-2026)
  8. 7.2.3 North America Pharma Excipients Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pharma Excipients Sales by Country
  2. 8.1.1 Europe Pharma Excipients Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pharma Excipients Sales by Country (2021-2026)
  4. 8.1.3 Europe Pharma Excipients Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pharma Excipients Market Size by Country
  6. 8.2.1 Europe Pharma Excipients Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pharma Excipients Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pharma Excipients Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pharma Excipients Sales by Country
  2. 9.1.1 Asia-Pacific Pharma Excipients Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pharma Excipients Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pharma Excipients Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pharma Excipients Market Size by Country
  6. 9.2.1 Asia-Pacific Pharma Excipients Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pharma Excipients Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pharma Excipients Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pharma Excipients Sales by Country
  2. 10.1.1 South America Pharma Excipients Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pharma Excipients Sales by Country (2021-2026)
  4. 10.1.3 South America Pharma Excipients Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pharma Excipients Market Size by Country
  6. 10.2.1 South America Pharma Excipients Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pharma Excipients Market Size by Country (2021-2026)
  8. 10.2.3 South America Pharma Excipients Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pharma Excipients Sales by Country
  2. 11.1.1 Middle East and Africa Pharma Excipients Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pharma Excipients Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pharma Excipients Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pharma Excipients Market Size by Country
  6. 11.2.1 Middle East and Africa Pharma Excipients Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pharma Excipients Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pharma Excipients Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pharma Excipients Value Chain Analysis
  2. 12.1.1 Pharma Excipients Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pharma Excipients Production Mode & Process
  7. 12.2 Pharma Excipients Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pharma Excipients Distributors
  10. 12.2.3 Pharma Excipients Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst